FDA Approves Idhifa for Some With Acute Myeloid Leukemia

For adults with relapsed or refractory AML who have an IDH2 genetic mutation
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Institutional, Source Type: news